首页 | 本学科首页   官方微博 | 高级检索  
检索        

转移性卵巢癌的腹腔化疗(附25例分析)
引用本文:商九香,张志毅.转移性卵巢癌的腹腔化疗(附25例分析)[J].现代妇产科进展,1995,4(2):107-108.
作者姓名:商九香  张志毅
作者单位:常熟市第六人民医院!215500(商九香,吴小华),上海医科大学肿瘤医院!200032(张志毅)
摘    要:转移性卵巢癌25例中15例子以腹腔化疗,平均疗程3.2个,另10例未予腹腔化疗。结果:腹腔化疗组的近期有效率为66.7%,未作腹腔化疗组为40%,两组差异有显著性(P<0.05)。对转移性卵巢癌的临床特征及腹腔化疗转移性卵巢癌的机理进行了讨论。

关 键 词:卵巢肿瘤  药物疗法  腹部  肿瘤转移  生存率

Intraperitoneal chemotherapy in metastatic ovarian cancer
ShangJiuxiang,Wu Xiaohua,Zhang Zhiyi.Intraperitoneal chemotherapy in metastatic ovarian cancer[J].Current Advances In Obstetrics and Gynecology,1995,4(2):107-108.
Authors:ShangJiuxiang  Wu Xiaohua  Zhang Zhiyi
Abstract:The authors reviewed 25 cases with metastatic ovarian cancer during 1985-1993 to evaluatethe shortterm curative effects and the impact of survival rate of intraperitoneal chemotherapy (IP ) . Fifteen of the 25 patients were given IP with average 3.2 courses of treatment, while the other 10 patients didn't receive IP.The results showed that the rate of shortterm curative effects in the patients with IP was 66.7%, while it was 40% in the patients without IP ( P<0.05 ) . The treatment mechanism of IIP in metastatic ovarian cancer was also discussed.
Keywords:Ovarian  neoplasms  Abdomen  Drug therapy  Neoplasm  metastasis  Survival rate
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号